Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Depreciation & Amortization (CF) (2018 - 2025)

Entera Bio has reported Depreciation & Amortization (CF) over the past 8 years, most recently at $7000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 36.36% year-over-year to $7000.0, compared with a TTM value of $30000.0 through Dec 2025, down 34.78%, and an annual FY2025 reading of $30000.0, down 34.78% over the prior year.
  • Depreciation & Amortization (CF) came in at $7000.0 for Q4 2025, down from $8000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $16000.0 in Q1 2022 to a low of $7000.0 in Q2 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $13500.0 (2021), compared with a mean of $12450.0.
  • The largest YoY upside for Depreciation & Amortization (CF) was 115.73% in 2021 against a maximum downside of 82.0% in 2021.
  • Over 5 years, Depreciation & Amortization (CF) stood at $14000.0 in 2021, then increased by 14.29% to $16000.0 in 2022, then fell by 18.75% to $13000.0 in 2023, then decreased by 15.38% to $11000.0 in 2024, then crashed by 36.36% to $7000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Depreciation & Amortization (CF) are $7000.0 (Q4 2025), $8000.0 (Q3 2025), and $7000.0 (Q2 2025).